Quantity size:

0.2ml

Concentration:

1mg/ml 癌症亮氨酸拉链下调因子1样蛋白抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

LDOC1 is a 146 amino acid nuclear protein that contains a leucine zipper-like motif and a proline-rich region that shares marked similarity with an SH3-binding domain. The protein localizes to the nucleus and is downregulated in some cancer cell lines. It is thought to regulate the transcriptional response mediated by the nuclear factor kB (NF-kB).癌症亮氨酸拉链下调因子1样蛋白抗体  The gene has been proposed as a tumor suppressor gene whose protein product may have an important role in the development and/or progression of some cancers. LDOC1L (Leucine zipper protein down-regulated in cancer cells-like), also known as MART6 (Mammalian retrotransposon-derived protein 6), is a 239 amino acid protein that belongs to the LDOC1 family.

癌症亮氨酸拉链下调因子1样蛋白抗体 Also known as:

dJ1033E15.2; DKFZp761O17121; LDOC1L; LDOCL_HUMAN; Leucine zipper down regulated in cancer 1 like; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon derived protein 6; Mammalian retrotransposon-derived protein 6; Mar6; Mart6; Protein LDOC1L.

Specificity:

●

Rabbit Polyclonal IgG,癌症亮氨酸拉链下调因子1样蛋白抗体  affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .

●

Immunogen: KLH conjugated synthetic peptide derived from human LDOC1L.

●

Predicted Molecular Weight: 26kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

癌症亮氨酸拉链下调因子1样蛋白抗体 Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl313Mu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)

kl313Ra01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)

kl820Hu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)

kl820Mu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)

kl820Ra01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)

kl353Ge01晚期糖基化终末产物(AGE)多克隆抗体Polyclonal Antibody to Advanced Glycation End Product (AGE)

kl929Hu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)

kl929Mu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)

kl929Ra01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)

kl367Hu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)

kl367Mu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)

kl367Ra01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)

kl377Hu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)

kl377Mu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)

kl377Ra01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)

kl400Hu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)

kl400Mu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)

kl400Ra01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)

kl372Hu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)

kl372Mu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)